Summary We quantified and examined the kinetics of DNA interstrand cross links (DNA-ISC) caused by Cis dichlorodiammine platinum (DDP) using the method of alkaline elution in 58 highly purified human ovarian tumours growing in primary culture. A large heterogeneity in both the quantity and kinetics of DDP induced DNA-ISC was These studies indicate that although there is a high interand intra-subject heterogeneity of DDP induced DNA-ISC in most cases the DNA-ISC last for long time intervals before being repaired.
Cis dichlorodiammine platinum (DDP) is an antitumour agent active in several human malignancies (Loehrer & Einhorn, 1984) . It is certainly the most effective available drug for the therapy of testicular (Einhorn & Donohue, 1977) and ovarian cancer (Neijt et al., 1984; Wiltshaw et al., 1979; Gruppo Interregionale Cooperativo Oncologico Ginecologia, 1987) . Although several types of DNA lesions caused by DDP in the form of adducts, DNA-protein cross links and DNA-DNA interstrand (DNA-ISC) and intrastrand-crosslinks have been characterised in vitro using purified DNA or cancer cells, the biochemical basis for the selectivity of this compound for germ cell carcinoma is still unknown. Studies conducted on cell lines derived from testicular cancer suggested that the long lasting DNA-ISC could be important for the remarkable activity of DDP against this human tumour (Bedford et al., 1988) . These data suggested that an inefficient repair of DDP-induced DNA damage could be at the basis of the selective activity of the drug against testicular cancer cells.
In order to obtain insight into the mechanisms of selectivity of DDP against ovarian carcinomas we have previously set up methods to grow purified human ovarian cancer cells in primary culture and have further demonstrated that they can be used for pharmacological studies (Balconi et al., 1988) . The rationale behind this work was based on the idea that primary cultures of tumours derived directly from patients could represent the in vivo biochemical and biological properties peculiar to ovarian cells better than established in vitro cancer cell lines (Balconi et al., 1988) , and assuming that the basis for the selective cytotoxicity of DDP may rely on the in vivo biological characteristics of ovarian cancer cells.
The aim of the present study was to evaluate whether information on the kinetics of DDP-induced DNA-ISC obtained from ovarian cancer cells growing in primary culture could provide some insight into the mechanisms of selectivity of DDP cytotoxicity against human ovarian cancer.
These studies indicate that although there is a high interand intra-subject heterogeneity of DDP induced DNA-ISC in most cases the DNA-ISC last for long time intervals before being repaired. Cell isolation and culture conditions All specimens of human ovarian tumours were collected under aseptic conditions. Solid tumours were enzymatically dissociated and purified by filtration through a 30 tLm mesh nylon filter, to yield virtually pure tumour cell cluster (Balconi et al., 1988) .
Materials and methods

Clinical
The ascitic fluids were centrifuged and the pellet was layered on a ficoll gradient and then purified by filtering the resulting cell suspension through a 30 Im mesh nylon filter and collecting the retained tumour cell cluster from the filter.
The homogeneity of the cell suspension was verified by morphological analysis and by flow cytometry. In the case of tumours with a DNA aneuploid, flow cytometric analysis of DNA content before and after the purification procedure was used to evaluate the ratio of diploid vs aneuploid. The positivity to monoclonal antibodies OC-125, MOV-2, MOV-19 was used to assess the homogeneity of human ovarian cancer cells. The cell prepartion was regarded as adequate for pharmacological studies when the percentage of normal cells was less than 3-5%.
Culture medium for cells derived from primary tumours and metastases was KOV, a modification of MCDB 151 previously described (Balconi et al., 1988) , supplemented with 3% FBS.
The cells derived from ascitic fluids were grown in RPMI 1640 supplemented with 10% FBS.
All products for tissue culture were purchased from Gibco Europe Ltd., UK except MCDB 151 (Sigma Chemical Co., St Louis, MO). (Young et al., 1985) (Vermorken et al., 1984) . After exposure to DDP, cells were washed with Phosphate Buffered Saline and incubated with drug free medium for the duration of the assay.
In some experiments, after DDP treatment, cells were exposed for 1 h to 0.1 M thiourea (TU) (Merck, Darmstadt, Germany) at the indicated times.
Cytotoxicity
Growing primary cultures exposed for 1 h to DDP were recovered in drug-free medium for 72 h. At this time cells were harvested and stained with 0.2% crystal violet dissolved in 0.1 M citric acid and the resulting stained suspension of nuclei was counted by a hemocytometer. At least six control cultures and six treated cultures were used for the cytotoxicity assay. The cytotoxicity was expressed as percentage of growth inhibition of treated cultures as compared to untreated controls.
Alkaline elution DNA-ISC were detected by the alkaline elution technique (Kohn et al., 1981) . Briefly, cells were labelled for 48 h with 0.05 1.Ci ml-I of '4C-thymidine (specific activity 61 fCi mmole-', New* England Nuclear). A post labelling chasing of 16 h in medium without 14C-thymidine was performed before DDP treatment.
At the end of the treatment or after different time intervals in drug-free medium, cells were subjected to 300 rads x-irradiation, and deposited on a 0.8 Zm pore size polycarbonate filter (Nucleopore Corp., Pleasanton, Ca.) and lysed with 5 ml of 'Iysis solution' (2% SDS, 0.02 M Na2 EDTA, 0.1 M glycine, pH = 10). Two ml of proteinase K solution (Merck, Darmstadt, Germany) (O.5 mg ml-') dissolved in lysis solution were then added to the upper chamber of a Swinnex filter holder, followed by 50 ml of 0.02 M EDTA solution adjusted to pH 12.1 with tetrapropylammonium hydroxide (Fluka, Germany) containing 0.1% SDS. Three hour fractions (approximately 6 ml) were collected, with fractions and filters processed as described (Kohn et al., 1981 
Results
We determined the kinetics of DNA-ISC induced by 1 h exposure to 40 tLM DDP in 58 primary cultures of epithelial ovarian cancer derived from 47 patients. Figure 1 shows the profile obtained by plotting the mean values of DNA-ISC against time determined at 6, 9 and 24 h after DDP treatment. The overall kinetics of DDP-induced DNA-ISC in cultures derived from primary tumours, metastases and ascites were similar with an increase of DNA-ISC for up to 9 h followed by a plateau between 9 and 24 h. The mean values appeared higher for metastases than for primary tumours and ascites, but the difference was not statistically significant. The levels of DNA-ISC measured in the six cultures derived from patients previously treated with chemotherapy including DDP appeared lower, but no statistical difference was found, due to their limited number. Table II reports the quantitative analysis of the data of DNA-ISC with mean and median values of the peak levels and AUC of DNA-ISC vs time for up to 24 h. The variability was large and the differences among the various groups were not statistically significant.
As previously demonstrated in cancer cell lines the correlation between DNA-ISC and growth inhibition caused by DDP was significant (Figure 2 ). In this study the evaluation was done in few cases. The reason was that the assay for cell growth of primary cultures, treated or untreated with DDP, was highly variable (the standard deviations of controls ranged between 10 and 45%), and it would have required many replicates for a meaningful statistical analysis. It was therefore impossible to carry it out in all cases tested, due to a limited amount of cells. Further a colony forming assay could not be applied for the purpose because our purification method resulted in the isolation of clusters of ovarian cancer cells and not of single cells (see Materials and methods). Finally, since the correlation between DNA-ISC and cytotoxicity has been previously reported in many cancer cell lines (Bedford et al., 1987; Ducore et al., 1982; Pera et al., 1981; Plooy et al., 1984; Zwelling et al., 1979a) , we intended to direct the focus of the present study on the less known characterisation of the kinetics of DDP-induced DNA-ISC, rather than to confirm an already well documented correlation between DNA-ISC and cytotoxicity. exposure with TU 0.1 M for 1 h. TU, at the concentration used, was reported to block the formation of new DNA-ISC (Zwelling et al., 1979b; Micetich et al., 1983) making an evaluation of the repair of DNA-ISC possible. Figure 5 shows two representative experiments clearly demonstrating a rapid decline of DDP-induced DNA-ISC after TU treatment whereas without TU much higher levels of DNA-ISC persisted for a longer time interval. These results support the hypothesis of a prolonged formation of DNA-ISC in the cells studied occurring from potentially crosslinkable monoadducts which were not repaired for at least 24 h after DDP treatment.
Discussion
Many studies were reported on DNA damage caused by DDP in numerous cancer cell lines. DDP caused DNAprotein cross-links (Zwelling et al., 1979a) , DNA-intrastrand and DNA-ISC (Zwelling et al., 1979a; Plooy et al., 1984; Fichtinger-Schepman et al., 1985a,b; (Plooy et al., 1984; Roberts & Friedlos, 1981; Eastman, 1982) . Although DDPinduced DNA-ISC are present in small amounts as compared to other DNA lesions they could be important because they alter profoundly the DNA structure and prevent the separation of the two strands of DNA needed for DNA replication and transcription. The importance of these DNA lesions is supported by a considerable amount of experimental evidence indicating that a good correlation exists between DDP-induced DNA-ISC and drug cytotoxicity (Bedford et al., 1987; Ducore et al., 1982; Zwelling et al., 1979a; Plooy et al., 1984; Pera et al., 1981) . Both with purified DNA and in whole cells DNA-ISC increase over time following the DNA binding of DDP-derived active species (Micetich et al., 1983; D'Incalci et al., 1985; Eastman, 1985) . It is reasonable to expect that in cells the kinetics of DNA-ISC are highly dependent on DNA repair processes and consequently, that tumours which are particularly sensitive to DDP do not repair the DNA lesions efficiently. We found that DDPinduced DNA-ISC in vitro in highly purified human ovarian cancer cells were present for a very long time after treatment. This finding corroborates the previously proposed hypothesis that the selectivity of DDP for some tumours is due to the low efficiency of repair of these DNA lesions (Dijt et al., 1988) . Bedford et al. (1988) (Eastman, 1987) preventing the formation of DNA-ISC. Further studies are needed to elucidate this point possibly using antibodies which recognise the main DNA adducts formed by DDP (Fichtinger-Schepman et al., 1985b; Sundquist et al., 1987; Poirier et al., 1982 (Young et al., 1985) ; in most of our cultures, instead, a protracted permanence of DNA-ISC was observed. We do not have an explanation for this discrepancy, but it may well be that the culture system used by us caused a selection of cells which were more sensitive to DDP action.
A very high quantitative and kinetic heterogeneity of DNA-ISC was observed among the cultures derived from different patients and also comparing cancer cell cultures derived from different biopsies or from ascites but all from the same patient. The heterogeneity of human tumours has been already put forward as an important obstacle to successful therapies (Wolf et al., 1987) . Intratumour cell-to-cell heterogeneity in glutathione content has been recently reported for human ovarian cancer biopsies (Lee et al., 1989 ). The present study provides evidence that in advanced ovarian cancer the heterogeneity of DDP-induced DNA damage is great. Data obtained from studying cancer cells derived from one biopsy do not necessarily apply to the entire population of cancer cells of the patient. In view of this finding it seems unlikely that the evaluation of DNA-ISC can be regarded as a useful assay to predict the final clinical outcome of DDP therapy in individual ovarian cancers. The heterogeneity in amounts and kinetics of DNA-ISC can also be attributed to several other mechanisms which have been recently demonstrated in cancer cell lines with a different degree of sensitivity to DDP (Bedford et al., 1987; Ducore et al., 1982) . A possible explanation could be a nonuniform DDP uptake (Waud, 1987) or a different repair efficiency of monoadducts and cross-links or a variable concentration of thioproteins (Andrews et al., 1987; Lee et al., 1989) which react with DDP lowering its binding capability to DNA. It would be important to develop methods which allow the measurements of biochemical determinants of DDP activity in individual cells. A better knowledge of the mechanisms is in fact essential to develop tools to counteract tumour resistance to DDP or to enhance the sensitivity to DDP in ovarian cancer. Considering that DNA repair processes appear to play an important role in determining the amount and the duration of DNA damage caused by DDP, it would be valuable to investigate the effects of DNA repair inhibitors given in combination with DDP.
